Absea Biotech
@abseabio.bsky.social
Absea Biotechnology | Empowering protein science
14,000+ recombinant proteins & 11,000+ monoclonal antibodies covering 70% of the human proteome.
Germany-USA-China
https://www.absea.bio/index.html
14,000+ recombinant proteins & 11,000+ monoclonal antibodies covering 70% of the human proteome.
Germany-USA-China
https://www.absea.bio/index.html
Want to see IP-MS validation results or protocol details?
We’re happy to share!
Message us or check out Pullroven® on Absea’s site: www.absea.bio/index.html
We’re happy to share!
Message us or check out Pullroven® on Absea’s site: www.absea.bio/index.html
Absea-Absea Biotechnology Ltd.
Absea develops, engineers and characterizes protein and antibody reagents with unprecedented throughput and quality. We strive to provide products, services and tools to break new ground in protein re...
www.absea.bio
October 21, 2025 at 9:32 AM
Want to see IP-MS validation results or protocol details?
We’re happy to share!
Message us or check out Pullroven® on Absea’s site: www.absea.bio/index.html
We’re happy to share!
Message us or check out Pullroven® on Absea’s site: www.absea.bio/index.html
Papers & contact:
@natgenet.nature.com perspective: www.nature.com/articles/s41...
Molecular and Cellular Proteomics research: www.mcponline.org/article/S153....
Interested in using N15? info@abseabio.com
@natgenet.nature.com perspective: www.nature.com/articles/s41...
Molecular and Cellular Proteomics research: www.mcponline.org/article/S153....
Interested in using N15? info@abseabio.com
A standardized framework for circulating blood proteomics - Nature Genetics
The field of blood proteomics faces an upsurge of data with the challenge of cross-study comparisons. This Perspective offers an in-depth analysis and proposes reference materials to enhance data integration and accelerate clinical translation.
www.nature.com
October 9, 2025 at 9:35 AM
Papers & contact:
@natgenet.nature.com perspective: www.nature.com/articles/s41...
Molecular and Cellular Proteomics research: www.mcponline.org/article/S153....
Interested in using N15? info@abseabio.com
@natgenet.nature.com perspective: www.nature.com/articles/s41...
Molecular and Cellular Proteomics research: www.mcponline.org/article/S153....
Interested in using N15? info@abseabio.com
Source: European Centre for Disease Prevention and Control (12-month Chikungunya virus disease case notification rate per 100 000 population, September 2024-August 2025).
October 2, 2025 at 9:41 AM
Source: European Centre for Disease Prevention and Control (12-month Chikungunya virus disease case notification rate per 100 000 population, September 2024-August 2025).
September 18, 2025 at 2:41 PM
For research use only. Not for diagnostic use.
👉 Contact us or visit our official page to learn more: www.absea.bio/index.html.
👉 Contact us or visit our official page to learn more: www.absea.bio/index.html.
Absea-Absea Biotechnology Ltd.
Absea develops, engineers and characterizes protein and antibody reagents with unprecedented throughput and quality. We strive to provide products, services and tools to break new ground in protein re...
www.absea.bio
September 16, 2025 at 11:28 AM
For research use only. Not for diagnostic use.
👉 Contact us or visit our official page to learn more: www.absea.bio/index.html.
👉 Contact us or visit our official page to learn more: www.absea.bio/index.html.